# A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis

> **NCT02311881** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 960 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Paracetamol 1000 mg SR tablets
- **DRUG:** Paracetamol 665 mg SR tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02311881
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 960 (ACTUAL)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02311881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02311881, "A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02311881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*